The onset of the COVID-19 pandemic in 2020 brought about an influx of patent related litigation. Experts postulate that both the financial pressures related to the pandemic and the increasing strength of the technology sector sparked this increase in litigation. Now, almost two years after the start of the pandemic, this surge continues and could be considered a new normal.
While governments and corporations around the globe push forward with vaccine development and potential cures, therapeutics litigation is now receiving attention. Rapid developments in this area are leading to securities and derivatives violations.
How can local, state and federal governments work together on specific policies to control the spread of COVID-19? How can attorneys quickly find medical experts for insight and guidance so that they can better serve their clients?
The rapid spread of a virus on the scale of COVID-19 has highlighted the role employers play in keeping illnesses from spreading in the workplace, and the risks (including litigation) that may arise. In order to help attorneys educate their clients on preventable workplace safety mistakes during and after COVID-19, Round Table Group has assembled…